Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days

Q: How long will it take to read this news story?

The story "Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days" has 656 words across 21 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days" was covered 9 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 315 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25687622</li><li>URL: https://beamstart.com/news/ami-organics-extends-rally-on-17383867223129</li></ul>

Business Standard Logo Business Standard 9h ago

Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days - Business Standard

Quick Summary:

The management believes, that on account of ramp-up of existing products, Fermion contract, and potential commercialisation of another CDMO contract in FY26E, Ami has strong revenue visibility.

In the first nine months of FY25, the company achieved revenue of Rs 698 crore, nearly equalling the revenue from operations of the entire previous financial year.

Shares of Ami Organics hit a new high of Rs 2,441.90, gaining 2 per cent on the BSE in Saturday’s intra-day trade, extending its past 3-day upward movement after the company reported robust earnings for the quarter ended December 2024 (Q3FY25).